Please find attached the disclosure pursuant to Chapter XIV - Centralized Database for Corporate Bonds/ Debenture in the prescribed format Annexure XIV-B.
Awaiting price reaction for this filing.
Fortis Healthcare has submitted a routine regulatory disclosure detailing three series of debentures (ISINs INE061F07044, INE061F07051, and INE061F07069) totaling ₹1,550 crore (₹500 Cr + ₹500 Cr + ₹550 Cr), all allotted and listed on BSE on December 19, 2024. All three instruments carry a CRISIL AA rating with a Stable outlook, assigned as new ratings in October 2024 and verified by CRISIL. No interest or redemption payments have been made during the reporting period, and the company has no history of defaults on any debt securities. The filing is submitted under SEBI's Master Circular for the centralized database of corporate bonds and debentures.
This is a standard compliance filing with no material change to Fortis's debt position or credit profile. The CRISIL AA/Stable rating reaffirms a strong investment-grade credit standing, providing comfort to existing and prospective debenture holders.